Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multidrug therapy in paucibacillary leprosy--a five year experience.

A Grugni1, N J Nadkarni, M S Kini

  • 1Lok Seva Sangam, D-1, Everard Nagar, Bombay.

Indian Journal of Leprosy
|October 1, 1988
PubMed
Summary

Multidrug therapy (MDT) for paucibacillary (PB) leprosy is effective, with 69% of patients inactive after 12 doses. However, 27% remained active, highlighting the need for at least 12 MDT doses for all PB patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of commercial histamine release test and autologous serum skin test in the diagnosis of autoimmune urticaria.

Indian journal of dermatology, venereology and leprology·2010
Same author

Fixed duration MDT in paucibacillary leprosy (classical and modified).

International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association·1993
Same author

Relapses in paucibacillary leprosy after MDT--a clinical study.

International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association·1990
Same author

Alagille syndrome. A case report.

Acta dermato-venereologica·1990
Same author

Childhood leprosy in Bombay: a clinico-epidemiological study.

Indian journal of leprosy·1988
Same author

[Rehabilitative treatment of patients with primary and secondary spinal cord neoplasms].

Minerva medica·1984

Area of Science:

  • Medical research
  • Infectious diseases
  • Dermatology

Background:

  • Leprosy, specifically paucibacillary (PB) leprosy, remains a significant public health concern.
  • Multidrug therapy (MDT) is the standard treatment for leprosy.
  • Determining optimal treatment duration for PB leprosy is crucial for effective disease control.

Purpose of the Study:

  • To evaluate the efficacy of multidrug therapy (MDT) in paucibacillary (PB) leprosy patients.
  • To determine the optimal number of MDT doses required for PB leprosy treatment.
  • To assess the long-term outcomes of MDT in PB leprosy.

Main Methods:

  • A cohort of 736 paucibacillary (PB) leprosy patients were administered multidrug therapy (MDT).
  • Patients received MDT for a minimum of 6 months.
  • Treatment outcomes, including disease activity, were monitored post-therapy.

Main Results:

  • After 6 doses of MDT, 44% of PB patients achieved inactive disease.
  • After 12 doses of MDT, 69% of PB patients achieved inactive disease.
  • A significant proportion, 27%, of patients remained active at the time of analysis.

Conclusions:

  • At least 12 doses of multidrug therapy (MDT) are recommended for paucibacillary (PB) leprosy patients.
  • Treatment duration should be standardized irrespective of leprosy type within the PB classification.
  • Further research may explore factors influencing treatment response in the 27% of active cases.

Related Experiment Videos